Day: July 12, 2022

WEYCO Group, Inc. Second Quarter 2022 Earnings Conference Call

WEYCO Group, Inc. Second Quarter 2022 Earnings Conference Call

Milwaukee, WI, July 12, 2022 (GLOBE NEWSWIRE) — WEYCO Group, Inc. (NASDAQ: WEYS), a global marketer of footwear, plans to announce second quarter 2022 financial results after the close on Tuesday, August 2, 2022.  Additionally, Thomas W. Florsheim, Jr., Chairman and CEO, will host a conference call on Wednesday, August 3, 2022, at 11:00 a.m. Eastern Time to discuss the financial results in more detail.  To participate in the call, you will first need to pre-register online. Pre-registration takes only a few minutes and you may pre-register at any time, including up to and after the call start time. To pre-register, please go to: https://register.vevent.com/register/BIa7409f4fc4524178a64746a943d62139. The pre-registration process will provide the conference call phone number and a passcode required to enter the call. A replay...

Continue reading

Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock Split

Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock Split

NEWTON, Mass., July 12, 2022 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that it has rescheduled its special meeting to, among other things, consider and vote on a proposed amendment to its amended and restated certificate of incorporation, as amended, in order to effect a reverse stock split of its issued and outstanding common stock. The Special Meeting will now be held on August 4, 2022, at 9:00 a.m., local time via live webcast. The new record date for the meeting is July 12, 2022. Allena will shortly begin mailing a copy of a new notice of special meeting, the original proxy statement for the special...

Continue reading

Vaxcyte Completes Enrollment of Phase 2 Portion of Phase 1/2 Clinical Proof-of-Concept Study Evaluating Safety, Tolerability and Immunogenicity of VAX-24 in Adults

Vaxcyte Completes Enrollment of Phase 2 Portion of Phase 1/2 Clinical Proof-of-Concept Study Evaluating Safety, Tolerability and Immunogenicity of VAX-24 in Adults

— Company Expects to Announce Topline Results from the Phase 1 and Phase 2 Portions of the Proof-of-Concept Study in October or November 2022 — — Vaxcyte Also Dosed First Participants in Separate VAX-24 Phase 2 Clinical Study in Adults 65 Years and Older, With Topline Data Expected in the First Half of 2023 — — VAX-24 is a 24-Valent Pneumococcal Conjugate Vaccine Designed to Deliver Broad-Spectrum Protection to Prevent Invasive Pneumococcal Disease and Pneumonia — SAN CARLOS, Calif., July 12, 2022 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced the completion of enrollment in the Phase 2 portion of the ongoing Phase 1/2 proof-of-concept...

Continue reading

Synchronoss Extends Platform Support for Alibaba and Google Cloud

Synchronoss Extends Platform Support for Alibaba and Google Cloud

Certifications Address the Need to Provide Customers with Multi-Cloud Environments to Deploy Synchronoss Personal Cloud and Synchronoss Email Suite Worldwide BRIDGEWATER, N.J., July 12, 2022 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in cloud, messaging and digital products and platforms, today announced that its namesake personal cloud and email suite have been certified on the Alibaba Cloud and Google Cloud, respectively. In addition to Amazon AWS and Oracle OCI already in use, the new certifications provide customers with multi-cloud environments to deploy and scale Synchronoss Personal Cloud and Synchronoss Email Suite globally. Synchronoss Personal Cloud and Synchronoss Email Suite are utilized by leading service providers around the world,...

Continue reading

ACM Research Introduces New Post-CMP Cleaning Tool for Silicon and SiC Wafer Substrate Manufacturing

ACM Research Introduces New Post-CMP Cleaning Tool for Silicon and SiC Wafer Substrate Manufacturing

Company leverages its extensive experience in single wet wafer cleans to enter post-CMP cleaning market FREMONT, Calif., July 12, 2022 (GLOBE NEWSWIRE) — ACM Research, Inc. (ACM) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging (WLP) applications, today announced the introduction of its new post-CMP cleaning tool. This is ACM’s first tool of its kind, serving as a cleaning step following the chemical mechanical planarization (CMP) process used to manufacture high quality substrates. It is available in 6- and 8- inch configurations for silicon carbide (SiC), and 8- and 12- inch configurations for silicon wafer manufacturing. The tool is available in wet-in dry-out (WIDO) and dry-in dry out (DIDO) configurations, with 2-, 4- and 6-chamber options to achieve maximum...

Continue reading

Safe Bulkers Announces Annual Meeting of Stockholders

Safe Bulkers Announces Annual Meeting of Stockholders

MONACO, July 12, 2022 (GLOBE NEWSWIRE) — Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that its Board of Directors has called an annual meeting of the stockholders to be held on September 26, 2022, at 14:00 local time at the Fairmont Hotel, 12 Avenue des Spélugues, Monte Carlo, 98000 Monaco. Stockholders of record at the close of business on August 1, 2022 will be entitled to receive notice of, and to vote at, the annual meeting, or any adjournments or postponements thereof. Formal notice of the meeting and/or the Company’s proxy statement will be sent to stockholders of the Company in due course. About Safe Bulkers, Inc. The Company is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly...

Continue reading

Root, Inc. Expands Reach with Three New Professional Sports Team Partnerships

Root, Inc. Expands Reach with Three New Professional Sports Team Partnerships

Root, Inc. announces three new sports partnerships with the Denver Broncos, the Cleveland Browns, and the Colorado Rockies COLUMBUS, Ohio, July 12, 2022 (GLOBE NEWSWIRE) — Root, Inc. (NASDAQ: ROOT), a leading technology company powering insurance solutions and the parent company of Root Insurance, announced partnerships with two National Football League teams and one Major League Baseball team. Root is now the official insurance partner of the Denver Broncos, Cleveland Browns, and additionally is a sponsor to the Colorado Rockies. Root’s name, logo, and advertisements will be integrated into the teams’ media, game-day graphics, and sponsored content. “We’re very excited and proud to be stepping deeper into the sports marketing world. These partnerships allow us to connect directly with our key audiences in important markets,” said...

Continue reading

UNITY Biotechnology to Present Clinical Data at the American Society of Retina Specialists (ASRS) 40th Annual Scientific Meeting

UNITY Biotechnology to Present Clinical Data at the American Society of Retina Specialists (ASRS) 40th Annual Scientific Meeting

SOUTH SAN FRANCISCO, Calif., July 12, 2022 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that 24-week clinical data results from the Phase 1 study of its lead senolytic candidate, UBX1325, in patients with diabetic macular edema and wet age-related macular degeneration will be presented at the American Society of Retina Specialists (ASRS) 40th Annual Scientific Meeting 2022, being held July 13-16, 2022. Details of the presentations are as follows: Title: UBX1325, A Novel Senolytic Therapy for Treatment Experienced Patients With Chronic DME or Wet AMD: 24-Week Results of a Phase 1 StudySession: Wet AMD 1 SymposiumDate & Time: Thursday, July 14 at 8:15 a.m. ETSpeaker: Raj Maturi, M.D., Midwest...

Continue reading

AB INTL GROUP Announces Intend to Abandon the Reverse Split  

AB INTL GROUP Announces Intend to Abandon the Reverse Split  

NEW YORK, July 12, 2022 (GLOBE NEWSWIRE) — AB International Group Corp. (OTCQB: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced the Company intend to abandon the reverse split. Ten trade days before 7/31/22 during July 18 through 7/29, the minimum closing bid price for the Company’s common stock must be $.01 or greater for ten consecutive trading days in order to continue trading on the OTCQB marketplace as per Section 4.1 of the OTCQB Standards. About AB International Group Corp.AB International Group Corp. is an intellectual property (IP) and movie investment and licensing firm, focused on acquisitions and development of various intellectual property. We are engaged to acquisition and distribution of movies. The Company engages highly anticipated video streaming service targeting...

Continue reading

NMI Holdings, Inc. to Announce Second Quarter 2022 Financial Results on August 2, 2022

NMI Holdings, Inc. to Announce Second Quarter 2022 Financial Results on August 2, 2022

EMERYVILLE, Calif., July 12, 2022 (GLOBE NEWSWIRE) — NMI Holdings, Inc. (NASDAQ: NMIH), the parent company of National Mortgage Insurance Corporation (National MI), today announced that it will report results for its second quarter ended June 30, 2022 after the market close on Tuesday, August 2, 2022. The company will hold a conference call and live webcast at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. The webcast will be available on the company’s website at https://ir.nationalmi.com/events-and-presentations. The call can be accessed by dialing (877) 270-2148 in the U.S. or (412) 902-6510 internationally by referencing NMI Holdings, Inc. A replay of the webcast as well as the earnings press release and any supplemental information will be available on the company’s website. About NMI Holdings NMI Holdings, Inc....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.